UTI

A Clinical Research Study to Eliminate Frequent UTIs

The ELIMINATE study aims to see if a new innovative treatment is safe and effective in treating drug-resistant UTIs.

Get Your Patient Form
Clinical Research Partners (7110 Forest Avenue, Suite 201, Richmond, VA 23226)
804-250-9859
Recruitment@ClinicalResearchRVA.com
Get Your Patient Form
Summary

25%-50% of women who experience a UTI will experience multiple recurrent episodes. The ELIMINATE study aims to see if a new innovative treatment is safe and effective in treating drug-resistant UTIs

Age

Women between the ages of 18 to 70

Qualifications

  • Have had at least one UTI in the past 12 months
  • Have a current UTI
  • Other selection criteria apply

Compensation

  • You may compensated up to $3,933.60 for participation.

Meet Our Team

Our experienced team will guide you through the process

Meet the Team

Dr. Call, co-founder of Clinical Research Partners, serves as President. He is a Certified Principle Investigator

Robert S. Call, MD, CPI

President

Annette Bennett, co-founder of Clinical Research Partners, serves as Chief Executive Officer and Research Director. She

Annette Bennett

Chief Executive Officer

Bo Vaughan is a native of Richmond, VA and forward-thinking health care strategist with a

Bo Vaughan, MD, MSHA, CPI

Medical Director

Jeanette Weller

EVP of Contracts and Budgets

Caitlin Vining

Controller CCRP

Kelly Craighead, BS, RN, CCRC

Regulatory Affairs Director

Carly McLaughlin, PharmD

Director of Pharmacy PharmD

Chrissy Robinson

Director of Quality Control

Erica Glenn, CCMA,CCRC

Manager of Off-site New Studies